Literature DB >> 19576936

Increased apoptosis and reduced replication efficiency of the E3 region-modified dl309 adenovirus in cancer cells.

Merilyn H Hibma1, Nicola C Real, Anna Wiles, Deirdre Dobson-Le, Brett R Dix, David Wynford-Thomas, Antony W Braithwaite, Janice A Royds.   

Abstract

The Adenovirus (Ad) dl309 mutant, which lacks several E3 region genes, has been used as the backbone for a number of replication selective cytopathic Ads designed to treat tumours. We report that dl309 has enhanced cytopathogenicity in a range of different cell lines when compared with Ad5. The E3 region modifications found in dl309 contributed to reduced late gene expression in both cocksackie-adenovirus receptor (CAR) positive and negative cells. We show that completion of the dl309 viral lifecycle was less efficient and apoptosis was triggered in the CAR negative K1 thyroid cancer-derived cell line. There was increased E1A expression in dl309-infected K1 cells, compared with Ad5, and significantly, whereas E1A in Ad5-infected cells was distributed both in the nuclear and cytoplasmic compartments, E1A was predominantly nuclear in dl309-infected K1 cells. From these results we conclude that the regions of dl309 that are deleted or otherwise modified can contribute to viral replication and inhibition of apoptosis, possibly indirectly by regulating E1A. These data have implications in the development of dl309-based Ads for the treatment of tumours in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19576936     DOI: 10.1016/j.virusres.2009.06.016

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  4 in total

Review 1.  Oncolytic herpes simplex virus vectors and chemotherapy: are combinatorial strategies more effective for cancer?

Authors:  Ryuichi Kanai; Hiroaki Wakimoto; Tooba Cheema; Samuel D Rabkin
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

Review 2.  Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer.

Authors:  Anna Maria Malfitano; Sarah Di Somma; Nella Prevete; Giuseppe Portella
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

3.  The Oncolytic Adenovirus XVir-N-31, in Combination with the Blockade of the PD-1/PD-L1 Axis, Conveys Abscopal Effects in a Humanized Glioblastoma Mouse Model.

Authors:  Moritz Klawitter; Ali El-Ayoubi; Jasmin Buch; Jakob Rüttinger; Maximilian Ehrenfeld; Eva Lichtenegger; Marcel A Krüger; Klaus Mantwill; Florestan J Koll; Markus C Kowarik; Per Sonne Holm; Ulrike Naumann
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

4.  Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer.

Authors:  Hiroyuki Araki; Hiroshi Tazawa; Nobuhiko Kanaya; Yoshinori Kajiwara; Motohiko Yamada; Masashi Hashimoto; Satoru Kikuchi; Shinji Kuroda; Ryuichi Yoshida; Yuzo Umeda; Yasuo Urata; Shunsuke Kagawa; Toshiyoshi Fujiwara
Journal:  Mol Ther Oncolytics       Date:  2022-09-13       Impact factor: 6.311

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.